Mercury Laboratories Limited (BOM:538964)
800.00
0.00 (0.00%)
At close: Jan 19, 2026
Mercury Laboratories Revenue
Mercury Laboratories had revenue of 190.09M INR in the quarter ending September 30, 2025, with 4.48% growth. This brings the company's revenue in the last twelve months to 773.75M, up 11.57% year-over-year. In the fiscal year ending March 31, 2025, Mercury Laboratories had annual revenue of 751.01M, down -0.61%.
Revenue (ttm)
773.75M
Revenue Growth
+11.57%
P/S Ratio
1.21
Revenue / Employee
1.54M
Employees
503
Market Cap
939.60M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 751.01M | -4.58M | -0.61% |
| Mar 31, 2024 | 755.59M | 2.25M | 0.30% |
| Mar 31, 2023 | 753.34M | 174.10M | 30.06% |
| Mar 31, 2022 | 579.24M | -106.78M | -15.56% |
| Mar 31, 2021 | 686.02M | 113.32M | 19.79% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bal Pharma | 2.95B |
| Mangalam Drugs & Organics | 2.38B |
| Zenith Drugs | 1.44B |
| Lactose (India) | 1.37B |
| Sotac Pharmaceuticals | 846.72M |
| Accretion Pharmaceuticals | 826.43M |
| Source Natural Foods and Herbal Supplements | 555.64M |
| Concord Drugs | 450.74M |